Compound library / Cognitive / Anxiolytic
Small peptide that blocks TREK-1 potassium channels, studied in animal models as a fast-acting antidepressant candidate (a more stable derivative of the original Spadin peptide).
| Category | Cognitive / Anxiolytic |
|---|---|
| Typical route | Subcutaneous |
| Half-life | Designed to be more stable than Spadin, but human half-life not established |
| Common dose range | Research-stage only — no established human dosing |
| Typical cycle length | Not established |
BioHack Track models PE-22-28 (Mini-Spadin) at a half-life of 1 hours, so every dose you log is decayed against that curve and the app shows what is still circulating — not just what you typed.
Reconstitute with bacteriostatic water.
Refrigerate after reconstitution.
Animal-study compound only; has not been tested in human depression trials as of this writing.
Track PE-22-28 (Mini-Spadin) in BioHack Track. Half-life, dose range and route come pre-filled from this library — log a dose and the app counts your vial down, models what is in your system, and puts it on the same chart as your labs and body composition.
These open a search of each database for PE-22-28 (Mini-Spadin) — they are not citations, and nothing here is evidence for any particular dose. The same links are in the app.
General reference compiled for use inside the app, not medical advice and not a recommendation to take anything. Dose ranges are what is commonly discussed, not a prescription. Talk to a qualified healthcare professional.